Dementia Dispatch Issue 14, January 2017

NNIDR Update – NNIDR Public Lecture Tour starts in March 2017

NNIDR kicks off its Public Lecture Tour Series during Brain Awareness Week in March 2017 and will continue through April.

The tour will feature 2016 Ryman Prize winner Professor Henry Brodaty and will have stops in each capital city in Australia. The tour will provide an insider snapshot at the current state of dementia research in Australia and the work of the institute.

Wicking Trust is also sponsoring the visit of Harry Johns, President and CEO – USA Alzheimer’s Association who will join Henry during Brain Awareness Week. Brain Awareness Week is 13 to 19 March 2017.

Professor Henry Brodaty will cover:

> What is Alzheimer’s and Dementia

> Update on cause/s of AD

> Prevention of AD and dementias

> Developments in diagnosis and treatments

> Maintaining quality of life for people with dementia and their families

> Hope for the future

The tour will be dementia friendly and supported by Alzheimer’s Australia and consumers are strongly encouraged to attend.

The tour will be a great opportunity for the dementia research community to come together along with consumers and forge stronger links for knowledge share and collaboration.

A full tour schedule will be available soon.

Stay in the loop with NNIDR membership
To receive direct updates on new dementia research schemes, become an NNIDR member.
Being a member of the NNIDR will give you access to exclusive Institute events and activities, including professional development opportunities. If you want to find out more about NNIDR membership, please visit https://www.nnidr.gov.au/membership-network

Fellow Profile

Dr Yen Ying Lim, NHMRC-ARC Dementia Research Development Fellow, Florey Institute of Neuroscience and Mental Health and the University of Melbourne

Dr Yen Ying Lim is an NHMRC-ARC Dementia Research Development Fellow at the Florey Institute of Neuroscience and Mental Health, The University of Melbourne. She completed her postdoctoral training in America, at Brown University and Washington University in St. Louis, and is currently involved in several international studies and clinical trials of Alzheimer’s disease. Dr Lim’s research interest centres around the integration and translation of key genetic, biological and cognitive markers of Alzheimer’s disease, to better inform early detection and risk of disease progression. In particular, she is interested in understanding (biological or behavioural) factors that may hasten or protect against the toxic effects of beta-amyloid as a direct manipulation of these factors, either behaviourally or pharmacologically, may modify or halt disease progression.

Prominent Dementia Researchers Honoured on Australia Day

Congratulations to two of Australia’s most prominent Dementia researchers!
Professor Colin Masters and Professor Leon Flicker were awarded the Order of Australia in the Australia Day 2017 Honours list.

Professor Masters, an NNIDR Expert Advisory Panel member, has been recognised for his 35 years of work into neurodegenerative diseases. This included the discovery, with German Professor Konrad Beyreuther, of how the amyloid protein in brain cells forms the plaques that build up and cause Alzheimer's.

Professor Flicker has been recognised for distinguished service to medicine and medical education in the field of geriatrics, as an academic and researcher, and through contributions to improved dementia prevention and care.

Congratulations to Dementia advocate Kate Swaffer, National Finalist for Australian of the year 2017

Kate Swaffer has been named a finalist for Australian of the year 2017 for her work on advocating for better services and outcomes for the 354,000 Australians who have received a diagnosis of dementia. Congratulations Kate and keep up the good work.

 

 

What’s on in Dementia Research

This section highlights activities, funding or events that may be of interest:

Current Funding Opportunities

EU Joint Programme—Neurodegenerative Diseases Research (JPND) 2017 call

The JPND call for multinational research projects for pathway analysis across neurodegenerative diseases is now open. As part of the Boosting Dementia Research Grants Scheme Priority Round 2 (PR2), NHMRC will provide up to $850,000 of funding per grant over a maximum of three years. This will be for Australian-based researchers participating in multinational consortia that have been favourably reviewed by JPND. Only research with a key focus on “Alzheimer’s disease or other dementias” will be funded through PR2.

Please refer to the JPND website for further information. Applicants from Australia intending to participate in the call should download the Australian information sheet. Further information is also on the NHMRC website.

Boosting Dementia Research GrantsOPEN

Boosting Dementia Research Leadership Fellowship SchemeOPEN

The submission of minimum data for both schemes closed on 18 January 2017. Applications for the schemes will close on Wednesday 8 February 2017.

For more information regarding these schemes, please visit https://www.nhmrc.gov.au/grants-funding/apply-funding

Events

Alzheimer’s Australia ACT – Research Forum on Dementia

Great Expectations Inspiring Hope Through Research
Monday, 27 February 2017
QT Hotel Canberra, 1 London Circuit, Canberra, ACT 2601

This Alzheimer’s Australia ACT event will bring together the leading minds in dementia research to Canberra. For more details including future announcements on keynote speakers and official program, please visit https://act.fightdementia.org.au/events

To submit your event, send the event details to nnidr.admin@alzheimers.org.au

Call for Papers

Have you published a research paper on dementia lately? Have you just had a paper accepted for publication? Let us know and we’ll include a link to it in our next issue! Simply send a link to your paper to nnidr.admin@alzheimers.org.au

Share your story

If you have a story to share on dementia, whether its research or personal experience, please contact nnidr.admin@alzheimers.org.au or phone 02 6217 9172. Your story may be published in the next newsletter, or used as vignettes in Institute-related communication materials, or created into a feature story and pitched to the media.